Welcome Guest | Register / Login

Therapeutic Market Research Reports

Sort By
Title Published Price
North America Sleep Apnea Diagnostic And Therapeutic Market Forecast 2019-2027
By Inkwood Research
KEY INSIGHTS The rise in the number of incidences of sleep apnea and lack of patient awareness regarding the disease in this region majorly drive the growth of the market in North America. The regional market for sleep apnea diagnostic and the...
Mar 2019 $ 1250
Europe Sleep Apnea Diagnostic And Therapeutic Market Forecast 2019-2027
By Inkwood Research
KEY FINDINGS The most common symptoms of sleep apnea are daytime sleepiness, loud snoring, and restless sleep. The Europe market for sleep apnea diagnostic and therapeutic market is expected to grow at a CAGR of 6.15% from 2019-2027. Germany, ...
Mar 2019 $ 1250
Intellia Therapeutics Inc (NTLA) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Intellia Therapeutics Inc (Intellia Therapeutics) is a genome editing company that develops proprietary curative therapeutics using CRISPR/Cas9 technology. The company develops in vivo programs for the treatment of liver diseases...
Mar 2019 $ 300
Crescita Therapeutics Inc (CTX) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Crescita Therapeutics Inc (Crescita Therapeutics) is a commercial dermatology company that offers prescription drug products for the treatment and care of skin conditions and diseases and their symptoms. The company's products co...
Mar 2019 $ 300
DiaMedica Therapeutics Inc (DMA) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary DiaMedica Therapeutics Inc (DiaMedica), formerly DiaMedica Inc is a clinical-stage biopharmaceutical company which develops innovative medicines for the treatment neurological and kidney diseases. Its lead product candidate DM-19...
Mar 2019 $ 300
Factor Therapeutics Ltd (FTT) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Factor Therapeutics Ltd (FTL), formerly Tissue Therapies Ltd, is a developer of wound care therapeutics. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. Its ...
Mar 2019 $ 300
Global Blood Therapeutics Inc (GBT) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Global Blood Therapeutics Inc (GBT) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes novel oral medicines for the treatment of grievous blood-based disorders. The company's lead drug candi...
Mar 2019 $ 300
Knight Therapeutics Inc (GUD) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Knight Therapeutics Inc (Knight Therapeutics) is a specialty pharmaceutical company focused on acquisition, licensing, marketing and distribution of prescription, consumer health products and medical devices. Its consumer health ...
Mar 2019 $ 300
Pluristem Therapeutics Inc (PSTI) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Pluristem Therapeutics Inc (Pluristem) is a clinical-stage biotherapy company that focuses on the development of placental-derived cell therapies. Its PLacental eXpanded (PLX) cells are adherent stromal cells that can be administ...
Mar 2019 $ 300
Bone Therapeutics SA (BOTHE) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. The company offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product...
Mar 2019 $ 300
Aimmune Therapeutics Inc (AIMT) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Aimmune Therapeutics Inc (Aimmune) formerly Allergen Research Corp is a clinical-stage biopharmaceutical company that develops proprietary product candidates for the treatment of peanut and other food allergies. The company's lea...
Mar 2019 $ 300
Audentes Therapeutics Inc (BOLD) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Audentes Therapeutics Inc (Audentes) is a biotechnology company that focuses on the development and commercialization of gene therapy products for rare diseases. The company's pipeline products include AT132, intended for the tre...
Mar 2019 $ 300
Cerenis Therapeutics Holding SA (CEREN) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Cerenis Therapeutics Holding SA (Cerenis) is a biopharmaceutical company that discovers and develops HDL therapies for the treatment of cardiovascular and metabolic diseases. The company develops a portfolio of HDL therapies incl...
Mar 2019 $ 300
Edge Therapeutics Inc (EDGE) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Edge Therapeutics Inc (Edge Therapeutics) is a clinical-stage biotechnology company that discovers, develops and commercializes hospital-based therapies. The company offers hospital based therapies capable of transforming treatme...
Mar 2019 $ 300
Shield Therapeutics Plc (STX) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Shield Therapeutics Plc (Shield Therapeutics) is a specialty pharmaceutical company that focus on the development and commercialization products for the treatment of anaemia associated with renal and gastrointestinal disorders. T...
Mar 2019 $ 300
vTv Therapeutics Inc (VTVT) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary vTv Therapeutics Inc (vTv), formerly TransTech Inc, is a pharmaceutical company that discovers, develops and commercializes human therapeutics. The company offers a pipeline of small molecule clinical and pre-clinical drug candid...
Mar 2019 $ 300
Voyager Therapeutics Inc (VYGR) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Voyager Therapeutics Inc (Voyager) is a clinical-stage gene therapy company that develops treatments for patients suffering from severe neurological diseases. The company provides treatment for adeno-associated virus gene therapy...
Mar 2019 $ 300
VistaGen Therapeutics Inc (VTGN) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary VistaGen Therapeutics Inc (VistaGen) is a clinical stage biopharmaceutical company that develops new generation medicines for depression and neuropsychiatric disorders. The company's pipeline product, AV-101, currently under Phas...
Mar 2019 $ 300
Prescient Therapeutics Ltd (PTX) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Prescient Therapeutics Ltd (Prescient Therapeutics), formerly Virax Holdings Ltd, is a clinical stage oncology company that develops novel drugs for the treatment of solid and hematological cancers. The company's lead drug candid...
Mar 2019 $ 300
Summit Therapeutics Plc (SUMM) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Summit Therapeutics Plc (Summit), formerly Summit Corp Plc is a clinical-stage drug discovery and development company that offer therapies. The company conducts research and development on the treatment of rare diseases and infec...
Mar 2019 $ 300
Akebia Therapeutics Inc (AKBA) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Akebia Therapeutics Inc (Akebia Therapeutics) is a biopharmaceutical company focused on the development and commercialization of novel therapeutics based on hypoxia inducible factor for patients with kidney disease and other meta...
Mar 2019 $ 300
Mateon Therapeutics Inc (MATN) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Mateon Therapeutics Inc (Mateon), formerly OXiGENE Inc is a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications. The company develops therapeutics to treat cancer and eye di...
Mar 2019 $ 300
Seres Therapeutics Inc (MCRB) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Seres Therapeutics Inc (Seres), is a microbiome therapeutics platform company that develops a novel class of biological drugs. The company creates a new class of medicines to treat diseases resulting from functional deficiencies ...
Mar 2019 $ 300
ProQR Therapeutics NV (PRQR) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary ProQR Therapeutics NV (ProQR) is a clinical-stage biotech company that discovers and develops drugs for the treatment of genetic disorders. The company's lead product candidate includes QR-010, a RNA-based oligonucleotide used fo...
Mar 2019 $ 300
Regulus Therapeutics Inc (RGLS) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Regulus Therapeutics Inc (Regulus Therapeutics) is a biopharmaceutical company that discovers and develops microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chain...
Mar 2019 $ 300
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy